Swedish Orphan Biovitrum AB (publ) (STO:SOBI)

STO:SOBI Revenue

Swedish Orphan Biovitrum AB had revenue of 7.84B SEK in the quarter ending June 30, 2026, with 27.00% growth. This brings the company's revenue in the last twelve months to 30.62B, up 13.54% year-over-year. In the year 2025, Swedish Orphan Biovitrum AB had annual revenue of 28.24B with 8.50% growth.

• Revenue (ttm): 30.62B
• Revenue Growth: +13.54%
• P/S Ratio: 5.19
• Revenue / Employee: 14.45M
• Employees: 1,969
• Market Cap: 158.85B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	28.24B	2.21B	8.50%
Dec 31, 2024	26.03B	3.90B	17.65%
Dec 31, 2023	22.12B	3.33B	17.74%
Dec 31, 2022	18.79B	3.26B	21.00%
Dec 31, 2021	15.53B	268.00M	1.76%
Dec 31, 2020	15.26B	1.01B	7.11%
Dec 31, 2019	14.25B	5.11B	55.90%
Dec 31, 2018	9.14B	2.63B	40.37%
Dec 31, 2017	6.51B	1.31B	25.10%
Dec 31, 2016	5.20B	1.98B	61.23%
Dec 31, 2015	3.23B	620.89M	23.82%
Dec 31, 2014	2.61B	430.28M	19.77%
Dec 31, 2013	2.18B	253.53M	13.18%
Dec 31, 2012	1.92B	12.33M	0.65%
Dec 31, 2011	1.91B	4.09M	0.21%
Dec 31, 2010	1.91B	609.77M	47.01%
Dec 31, 2009	1.30B	156.39M	13.71%
Dec 31, 2008	1.14B	-	-

Data Source: Fiscal.ai Last updated: Jul 16, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error